跳至主要内容
临床试验/CTRI/2018/10/016219
CTRI/2018/10/016219尚未招募2 期

Use of Theta burst stimulation in adolescents with depression: Evaluating acceptability, safety, tolerability, and efficacy.

NIMHANS hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2018年1月11日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
30
试验地点
1
主要终点
To measure Adverse effect of TMS using structured tool devised by Pascal Leone , Visual analogue scale , Neuropsychological tests and rate of discontinuation

研究概览

简要总结

Primary purpose

  1. To study safety , tolerability and acceptance of TBS in adolescents with depression

  2. To measure the efficacy of TMS as an add on to standard of care in adolescents with depression.

Hypothesis

  1. TMS will be well tolerated by adolescents with minimal to none adverse effects and accepted by adolescents and their families

  2. TMS will reduce severity of depression .

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
12.00 Year(s) 至 18.00 Year(s)(—)
性别
All

入选标准

  • 12-18 years of age, either gender
  • Moderate – Severe Depression (as per DSM 5)
  • In patients in department of child & adolescent psychiatry,NIMHANS
  • Parents willing to consent for the study.

排除标准

  • Intracranial implants (cochlear implants, aneurysmal clips)
  • Acute emergencies like high suicidal risk and catatonia where ECT is considered as a first line treatment
  • Current/Past history / family history of epilepsy
  • Adolescents on Methylphenidate , Bupropion , Clozapine, Tricyclic antidepressants
  • Active Neurological illness / head injury
  • Autism spectrum disorder , Intellectual developmental disorder
  • Organic mood disorders
  • Chronic physical illness.

结局指标

主要结局

To measure Adverse effect of TMS using structured tool devised by Pascal Leone , Visual analogue scale , Neuropsychological tests and rate of discontinuation

时间窗: baseline , daily after TMS sessions , 1 week , 2 week , 3 month

次要结局

  • acceptability of TBS as a treatment modality as measured by ratio of those who accept TMS as treatment modality to those who were offered same(2 weeks)
  • efficacy in terms of change in severity of depression over period of 12 weeks as measured by fall in CDRS-R scores(Baseline , 2 weeks , 3 months)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验